ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
Canada - TSX:AND - CA0342231077 - Common Stock
54.97 CAD
+0.01 (+0.02%)
We assign a fundamental rating of 6 out of 10 to AND. AND was compared to 15 industry peers in the Health Care Providers & Services industry. AND has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AND is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
AND had a positive operating cash flow in the past year.
Each year in the past 5 years AND has been profitable.
In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.81%, AND is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Return On Equity of AND (15.35%) is better than 86.67% of its industry peers.
The Return On Invested Capital of AND (11.76%) is better than 86.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AND is above the industry average of 7.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROIC | 11.76% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
AND's Profit Margin of 10.37% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
In the last couple of years the Profit Margin of AND has remained more or less at the same level.
AND has a better Operating Margin (13.99%) than 86.67% of its industry peers.
In the last couple of years the Operating Margin of AND has remained more or less at the same level.
AND has a worse Gross Margin (33.85%) than 60.00% of its industry peers.
In the last couple of years the Gross Margin of AND has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AND is creating some value.
AND has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, AND has more shares outstanding
The debt/assets ratio for AND is higher compared to a year ago.
2.2 Solvency
AND has an Altman-Z score of 6.13. This indicates that AND is financially healthy and has little risk of bankruptcy at the moment.
AND has a better Altman-Z score (6.13) than 93.33% of its industry peers.
The Debt to FCF ratio of AND is 1.80, which is an excellent value as it means it would take AND, only 1.80 years of fcf income to pay off all of its debts.
AND has a Debt to FCF ratio of 1.80. This is amongst the best in the industry. AND outperforms 100.00% of its industry peers.
AND has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
AND's Debt to Equity ratio of 0.21 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Altman-Z | 6.13 |
ROIC/WACC1.43
WACC8.22%
2.3 Liquidity
A Current Ratio of 1.35 indicates that AND should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.35, AND belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
AND has a Quick Ratio of 1.30. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
AND's Quick ratio of 1.30 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 1.96% over the past year.
The Earnings Per Share has been growing by 14.82% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.34% in the past year.
AND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.53% yearly.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
3.2 Future
AND is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.16% yearly.
AND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y7.39%
EPS Next 2Y10.57%
EPS Next 3Y9.16%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.24, which means the current valuation is very expensive for AND.
Based on the Price/Earnings ratio, AND is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.03, AND is valued a bit more expensive.
The Price/Forward Earnings ratio is 28.46, which means the current valuation is very expensive for AND.
Based on the Price/Forward Earnings ratio, AND is valued a bit cheaper than 73.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AND to the average of the S&P500 Index (22.27), we can say AND is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.46 |
4.2 Price Multiples
AND's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AND is cheaper than 66.67% of the companies in the same industry.
AND's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 14.03 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AND may justify a higher PE ratio.
PEG (NY)4.77
PEG (5Y)2.38
EPS Next 2Y10.57%
EPS Next 3Y9.16%
5. Dividend
5.1 Amount
With a yearly dividend of 0.88%, AND is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.13, AND pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.88, AND pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.88% |
5.2 History
The dividend of AND decreases each year by -34.89%.
AND has been paying a dividend for over 5 years, so it has already some track record.
AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
26.73% of the earnings are spent on dividend by AND. This is a low number and sustainable payout ratio.
DP26.73%
EPS Next 2Y10.57%
EPS Next 3Y9.16%
TSX:AND (11/4/2025, 7:00:00 PM)
54.97
+0.01 (+0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners76.5%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap2.15B
Revenue(TTM)650.58M
Net Income(TTM)67.49M
Analysts50
Price Target56.92 (3.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.88% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)-7.95%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)-0.88%
Revenue NQ rev (3m)-3.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.46 | ||
| P/S | 3.31 | ||
| P/FCF | 21.69 | ||
| P/OCF | 17.59 | ||
| P/B | 4.89 | ||
| P/tB | 17.04 | ||
| EV/EBITDA | 14.03 |
EPS(TTM)1.56
EY2.84%
EPS(NY)1.93
Fwd EY3.51%
FCF(TTM)2.53
FCFY4.61%
OCF(TTM)3.13
OCFY5.69%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)4.77
PEG (5Y)2.38
Graham Number19.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROCE | 16.09% | ||
| ROIC | 11.76% | ||
| ROICexc | 13.13% | ||
| ROICexgc | 34.45% | ||
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% | ||
| FCFM | 15.25% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexgc growth 3Y-1.36%
ROICexgc growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 32.65% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.6% | ||
| Profit Quality | 147.02% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.13 |
F-Score5
WACC8.22%
ROIC/WACC1.43
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y7.39%
EPS Next 2Y10.57%
EPS Next 3Y9.16%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year74.49%
EBIT Next 3Y25.3%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%
ANDLAUER HEALTHCARE GROUP IN / AND.CA FAQ
What is the ChartMill fundamental rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to AND.CA.
What is the valuation status for AND stock?
ChartMill assigns a valuation rating of 3 / 10 to ANDLAUER HEALTHCARE GROUP IN (AND.CA). This can be considered as Overvalued.
How profitable is ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ANDLAUER HEALTHCARE GROUP IN (AND.CA) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for AND stock?
The Price/Earnings (PE) ratio for ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 35.24 and the Price/Book (PB) ratio is 4.89.
What is the financial health of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
The financial health rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 8 / 10.